Picture of Marker Therapeutics logo

MRKR Marker Therapeutics Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for Marker Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
C2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-148-21.4-28.7-41.9-29.9
Depreciation
Non-Cash Items1325.525.796.985.98
Unusual Items
Other Non-Cash Items
Changes in Working Capital1.04-2.482.45.47-5.81
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-14.5-18.3-20-27.3-27
Capital Expenditures-0.148-0.375-9.25-3.13-4.95
Purchase of Fixed Assets
Cash from Investing Activities-0.148-0.375-9.25-3.13-4.95
Net Issuance / Retirement of Stock
Cash from Financing Activities71.20.8166.7452.60.202
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash56.6-17.8-22.622.1-31.7